Posted On: 05/06/2014 11:36:45 AM
Post# of 94298
$ACT News
Corner drug store may move overseas to save on taxes
6:30 a.m. April 16, 2014
- Al Lewis
Intuitive Surgical slumps; Facebook extends rally
3:41 p.m. April 9, 2014
- Saumya Vaishampayan
Actavis acquires Silom Medical for $100 million
10:19 a.m. April 1, 2014
- MarketWatch.com
The 10 most overbought stocks in the S&P 500 index
12:19 p.m. March 25, 2014
- The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares
1:33 p.m. March 14, 2014
- blogs.marketwatch.com
Mylan to start selling generic Celebrex in May
7:22 a.m. March 13, 2014
- MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted
3:21 p.m. March 12, 2014
- blogs.marketwatch.com
Staples awash in red; eBay up as Icahn posts new letter
4:09 p.m. March 6, 2014
- Victor Reklaitis
Icahn Enterprises reports profit up 144% in 2013
10:22 a.m. March 3, 2014
- MarketWatch
Citadel hedge fund’s recent moves
11:12 a.m. Feb. 25, 2014
- Insider Monkey
Stocks rally; S&P 500 ends right below record
4:45 p.m. Feb. 24, 2014
- Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave
5:31 a.m. Feb. 24, 2014
- Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings
11:21 a.m. Feb. 20, 2014
- blogs.marketwatch.com
Actavis swings to loss on charges, write-downs
8:03 a.m. Feb. 20, 2014
- MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says
1:59 p.m. Feb. 19, 2014
- blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal
11:03 a.m. Feb. 19, 2014
- blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row
4:38 p.m. Feb. 18, 2014
- Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal
4:10 p.m. Feb. 18, 2014
- Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap
4:06 p.m. Feb. 18, 2014
- blogs.marketwatch.com
Forest buyout may not spell the end of dealmaking for Actavis
3:00 p.m. Feb. 18, 2014
- blogs.marketwatch.com
10-Q: ACTAVIS PLC
5:15 p.m. May 5, 2014
- Edgar Online - (EDG = 10Q, 10K)
Hottest Healthcare Stocks Now – HMSY ACAD ACT MWIV
1:45 p.m. May 5, 2014
- InvestorPlace.com
Best Five Stocks Over $100
10:07 a.m. May 3, 2014
- 247WallSt.com
AstraZeneca Nixes New Bid As Pfizer Woos British PM
1:11 p.m. May 2, 2014
- Investors Business Daily
Earnings Beat at Endo, Shares Up on Improved Outlook - Analyst Blog
12:10 p.m. May 2, 2014
- Zacks.com
Tyco Eyes 'Business Friendly' Ireland
8:35 a.m. May 2, 2014
- The Wall Street Journal Interactive Edition
What's With All The Healthcare And Pharmaceutical Mergers?
5:25 p.m. May 1, 2014
- TheStreet.com
Avanir Wins Lawsuit, Shares Up - Analyst Blog
4:39 p.m. May 1, 2014
- Zacks.com
A Look At World Stocks' Q1: Shire, Actavis, NXP Semi
4:32 p.m. May 1, 2014
- Investors Business Daily
Mylan Beats on Earnings, Misses on Sales - Analyst Blog
1:17 p.m. May 1, 2014
- Zacks.com
Company News for May 01, 2014 - Corporate Summary
10:06 a.m. May 1, 2014
- Zacks.com
Actavis plc (ACT): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
8:00 a.m. May 1, 2014
- Zacks.com
Actavis PLC (ACT): Today's Featured Health Care Winner
5:00 p.m. April 30, 2014
- TheStreet.com
Actavis Beats Q1 Views, Looks To Supersized Future
4:28 p.m. April 30, 2014
- Investors Business Daily
Actavis Tops Q1 Earnings & Sales Estimates - Analyst Blog
4:25 p.m. April 30, 2014
- Zacks.com
Avanir up on patent case decision
2:55 p.m. April 30, 2014
- Seeking Alpha
Actavis Management Discusses Q1 2014 Results - Earnings Call Transcript
2:20 p.m. April 30, 2014
- Seeking Alpha
Actavis Q1 Earnings Beat On Generic Cymbalta Surprise
10:10 a.m. April 30, 2014
- Investors Business Daily
Zacks Rank #1 Additions for Wednesday - Tale of the Tape
9:30 a.m. April 30, 2014
- Zacks.com
Biggest Movers in Healthcare Stocks Now – ACT HSP FRX AZN
8:30 a.m. April 30, 2014
- InvestorPlace.com
Financial Results, Study Results, and Conference Schedules - Analyst Notes on Actavis, BMS, Baxter, Biogen Idec and AbbVie
9:00 a.m. Today9:00 a.m. May 6, 2014
- PR Newswire - PRF
Actavis and Forest Announce Effectiveness of Registration Statement
on Form S-4
9:02 a.m. May 5, 2014
- BusinessWire - BZX
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4
9:00 a.m. May 5, 2014
- PR Newswire - PRF
Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline
and Drop Tax Rate, an Industrial Info News Alert
6:31 a.m. April 30, 2014
- Marketwire
Stocks Close to Reporting their Earnings -- Research on Actavis, NYSE Community Bancorp, Hess, and Dominion Resources
4:36 a.m. April 30, 2014
- PR Newswire - PRF
Actavis Sues FDA Regarding Delay of Generic Celebrex® Approval
5:14 p.m. April 28, 2014
- PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard
8:00 a.m. April 28, 2014
- PR Newswire - PRF
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts
8:00 a.m. April 25, 2014
- PR Newswire - PRF
Actavis Announces Celebrex® Patent Challenge Settlement
9:20 a.m. April 24, 2014
- PR Newswire - PRF
Actavis Announces Departure of G. Frederick Wilkinson, President, Actavis Global R&D
9:03 a.m. April 21, 2014
- PR Newswire - PRF
Actavis to Acquire Four Products from Akorn
4:15 p.m. April 17, 2014
- PR Newswire - PRF
Actavis and Forest Laboratories Receive FTC Second Request Under
Hart-Scott-Rodino
4:05 p.m. April 17, 2014
- BusinessWire - BZX
Actavis and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Rodino
4:05 p.m. April 17, 2014
- PR Newswire - PRF
Actavis Announces Agreement Related to Generess® FE Patent Challenge Litigation
8:00 a.m. April 15, 2014
- PR Newswire - PRF
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin
8:00 a.m. April 11, 2014
- PR Newswire - PRF
Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines
12:30 p.m. April 10, 2014
- PR Newswire - PRF
Actavis Launches Asia Pacific Regional Headquarters in Singapore
8:00 p.m. April 2, 2014
- PR Newswire - PRF
Particle Sciences and Actavis Enter into Joint Development Agreement
11:00 a.m. April 1, 2014
- PR Newswire - PRF
Actavis Acquires Silom Medical Company
8:30 a.m. April 1, 2014
- PR Newswire - PRF
Actavis Completes Divestiture of Commercial Operations in Seven Western European Countries to Aurobindo Pharma Limited
8:00 a.m. April 1, 2014
- PR Newswire - PRF
Corner drug store may move overseas to save on taxes
6:30 a.m. April 16, 2014
- Al Lewis
Intuitive Surgical slumps; Facebook extends rally
3:41 p.m. April 9, 2014
- Saumya Vaishampayan
Actavis acquires Silom Medical for $100 million
10:19 a.m. April 1, 2014
- MarketWatch.com
The 10 most overbought stocks in the S&P 500 index
12:19 p.m. March 25, 2014
- The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares
1:33 p.m. March 14, 2014
- blogs.marketwatch.com
Mylan to start selling generic Celebrex in May
7:22 a.m. March 13, 2014
- MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted
3:21 p.m. March 12, 2014
- blogs.marketwatch.com
Staples awash in red; eBay up as Icahn posts new letter
4:09 p.m. March 6, 2014
- Victor Reklaitis
Icahn Enterprises reports profit up 144% in 2013
10:22 a.m. March 3, 2014
- MarketWatch
Citadel hedge fund’s recent moves
11:12 a.m. Feb. 25, 2014
- Insider Monkey
Stocks rally; S&P 500 ends right below record
4:45 p.m. Feb. 24, 2014
- Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave
5:31 a.m. Feb. 24, 2014
- Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings
11:21 a.m. Feb. 20, 2014
- blogs.marketwatch.com
Actavis swings to loss on charges, write-downs
8:03 a.m. Feb. 20, 2014
- MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says
1:59 p.m. Feb. 19, 2014
- blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal
11:03 a.m. Feb. 19, 2014
- blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row
4:38 p.m. Feb. 18, 2014
- Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal
4:10 p.m. Feb. 18, 2014
- Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap
4:06 p.m. Feb. 18, 2014
- blogs.marketwatch.com
Forest buyout may not spell the end of dealmaking for Actavis
3:00 p.m. Feb. 18, 2014
- blogs.marketwatch.com
10-Q: ACTAVIS PLC
5:15 p.m. May 5, 2014
- Edgar Online - (EDG = 10Q, 10K)
Hottest Healthcare Stocks Now – HMSY ACAD ACT MWIV
1:45 p.m. May 5, 2014
- InvestorPlace.com
Best Five Stocks Over $100
10:07 a.m. May 3, 2014
- 247WallSt.com
AstraZeneca Nixes New Bid As Pfizer Woos British PM
1:11 p.m. May 2, 2014
- Investors Business Daily
Earnings Beat at Endo, Shares Up on Improved Outlook - Analyst Blog
12:10 p.m. May 2, 2014
- Zacks.com
Tyco Eyes 'Business Friendly' Ireland
8:35 a.m. May 2, 2014
- The Wall Street Journal Interactive Edition
What's With All The Healthcare And Pharmaceutical Mergers?
5:25 p.m. May 1, 2014
- TheStreet.com
Avanir Wins Lawsuit, Shares Up - Analyst Blog
4:39 p.m. May 1, 2014
- Zacks.com
A Look At World Stocks' Q1: Shire, Actavis, NXP Semi
4:32 p.m. May 1, 2014
- Investors Business Daily
Mylan Beats on Earnings, Misses on Sales - Analyst Blog
1:17 p.m. May 1, 2014
- Zacks.com
Company News for May 01, 2014 - Corporate Summary
10:06 a.m. May 1, 2014
- Zacks.com
Actavis plc (ACT): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
8:00 a.m. May 1, 2014
- Zacks.com
Actavis PLC (ACT): Today's Featured Health Care Winner
5:00 p.m. April 30, 2014
- TheStreet.com
Actavis Beats Q1 Views, Looks To Supersized Future
4:28 p.m. April 30, 2014
- Investors Business Daily
Actavis Tops Q1 Earnings & Sales Estimates - Analyst Blog
4:25 p.m. April 30, 2014
- Zacks.com
Avanir up on patent case decision
2:55 p.m. April 30, 2014
- Seeking Alpha
Actavis Management Discusses Q1 2014 Results - Earnings Call Transcript
2:20 p.m. April 30, 2014
- Seeking Alpha
Actavis Q1 Earnings Beat On Generic Cymbalta Surprise
10:10 a.m. April 30, 2014
- Investors Business Daily
Zacks Rank #1 Additions for Wednesday - Tale of the Tape
9:30 a.m. April 30, 2014
- Zacks.com
Biggest Movers in Healthcare Stocks Now – ACT HSP FRX AZN
8:30 a.m. April 30, 2014
- InvestorPlace.com
Financial Results, Study Results, and Conference Schedules - Analyst Notes on Actavis, BMS, Baxter, Biogen Idec and AbbVie
9:00 a.m. Today9:00 a.m. May 6, 2014
- PR Newswire - PRF
Actavis and Forest Announce Effectiveness of Registration Statement
on Form S-4
9:02 a.m. May 5, 2014
- BusinessWire - BZX
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4
9:00 a.m. May 5, 2014
- PR Newswire - PRF
Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline
and Drop Tax Rate, an Industrial Info News Alert
6:31 a.m. April 30, 2014
- Marketwire
Stocks Close to Reporting their Earnings -- Research on Actavis, NYSE Community Bancorp, Hess, and Dominion Resources
4:36 a.m. April 30, 2014
- PR Newswire - PRF
Actavis Sues FDA Regarding Delay of Generic Celebrex® Approval
5:14 p.m. April 28, 2014
- PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard
8:00 a.m. April 28, 2014
- PR Newswire - PRF
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts
8:00 a.m. April 25, 2014
- PR Newswire - PRF
Actavis Announces Celebrex® Patent Challenge Settlement
9:20 a.m. April 24, 2014
- PR Newswire - PRF
Actavis Announces Departure of G. Frederick Wilkinson, President, Actavis Global R&D
9:03 a.m. April 21, 2014
- PR Newswire - PRF
Actavis to Acquire Four Products from Akorn
4:15 p.m. April 17, 2014
- PR Newswire - PRF
Actavis and Forest Laboratories Receive FTC Second Request Under
Hart-Scott-Rodino
4:05 p.m. April 17, 2014
- BusinessWire - BZX
Actavis and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Rodino
4:05 p.m. April 17, 2014
- PR Newswire - PRF
Actavis Announces Agreement Related to Generess® FE Patent Challenge Litigation
8:00 a.m. April 15, 2014
- PR Newswire - PRF
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin
8:00 a.m. April 11, 2014
- PR Newswire - PRF
Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines
12:30 p.m. April 10, 2014
- PR Newswire - PRF
Actavis Launches Asia Pacific Regional Headquarters in Singapore
8:00 p.m. April 2, 2014
- PR Newswire - PRF
Particle Sciences and Actavis Enter into Joint Development Agreement
11:00 a.m. April 1, 2014
- PR Newswire - PRF
Actavis Acquires Silom Medical Company
8:30 a.m. April 1, 2014
- PR Newswire - PRF
Actavis Completes Divestiture of Commercial Operations in Seven Western European Countries to Aurobindo Pharma Limited
8:00 a.m. April 1, 2014
- PR Newswire - PRF
(0)
(0)
